The Biden administration at Washington has finally agreed to waiver the intellectual property protection for speeding up the production of COVID vaccines.

Intellectual Property rights of vaccine makers to potentially enable companies in developing countries to manufacture their own version of COVID-19 vaccines. 

“The administration believes strongly in intellectual property protections, but in service US Trade representative, Katherine Tai said that the US would support waiving these of ending this pandemic, supports the waiver of those protections for Covid-19 vaccines,” Ms. Tai said in a statement.

Pharmaceutical companies, however, oppose it, saying the waiver won’t provide the short-term results proponents think it will, partly because of the challenge of setting up complex new production facilities to manufacture the vaccines.